ADM recently announced that it has opened a new production facility in Valencia, Spain, to help meet rising global demand for probiotics, postbiotics and other products that support health and wellbeing.
The production facility represents an investment just above US$30 million and a more than five-fold increase in the company’s production capacity, increasing it to 50 metric tonnes per year. The facility will enable ADM to supply growing markets for probiotics and postbiotics in the US, Asia Pacific and Europe.
The company has said it expects its customer base will more than triple over the next five years as more people recognise links between the gut microbiome and many aspects of health and look for products tailored to their needs.
The facility will also help the company fulfil its expansion strategy in the health and wellbeing sector, as its ambition is to increase health and wellness revenue from over $500 million in 2022 to $2 billion within 10 years.
“Health and well-being is one of the three enduring trends powering ADM’s growth strategy: Consumers are increasingly aware of the role their gut microbiome can play in their everyday lives, and they’re seeking nutrition solutions that are backed up by science-based research,” said Mark Lotsch, President, Global Health & Wellness at ADM. “ADM is a leader in meeting this growing global demand, and we’re continuing to invest in the cutting edge of health and nutrition.”
The site will produce the company’s probiotic BPL1 and the heat-treated BPL1 postbiotic, as well as other ADM proprietary strains supplying a range of customers. BPL1 is suited to a range of applications and can be incorporated into better-for-you snacks.
The new facility is located close to the company’s research and development centre in the University of Valencia Scientific Park, where ADM scientists undertake activity including next-generation genome sequencing and early-stage testing of new bacterial strains.
Read more latest industry news and developments in our free to download magazine.